One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Artificial Cornea and Corneal Implant Market

人工角膜および角膜インプラント市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2026年


[ 英語タイトル ] Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) - Global Forecast to 2026


Product Code : MNMHC00112023
Survey : MarketsandMarkets
Publish On : April, 2021
Number of Pages : 152
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

The global artificial cornea and corneal implant market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026. Market growth is largely driven by the The growing geriatric population and the rising prevalence of eye diseases are the major drivers for the artificial cornea and corneal implants market. The increasing prevalence of eye disorders and government initiatives to control visual impairment are further boosting the market growth.
However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of this market during the forecast period.
“Human cornea segment accounted for the largest share of artificial cornea and corneal implant market in 2020”

On the basis of type, the artificial cornea and corneal implants market is segmented into human cornea and artificial cornea. In 2020, the human cornea segment accounted for the largest share of the artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising awareness regarding corneal transplantation and eye tissue donations, especially in developing economies.

“Penetrating keratoplasty segment accounted for the largest share of artificial cornea and corneal implant market in 2020”

On the basis of transplant type, the artificial cornea and corneal implants market is segmented into penetrating keratoplasty, endothelial keratoplasty, and other transplants (including anterior lamellar keratoplasty (ALK) and keratoprosthesis). In 2020, the penetrating keratoplasty segment accounted for the largest share of the global artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising number of people suffering from eye disorders such as infectious keratitis and injury of the eyeball.

“North America accounted for the largest share of the artificial cornea and corneal implant market in 2020.”
Geographically, the artificial cornea and corneal implant market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. In 2020, North America accounted for the largest share of the global artificial cornea and corneal implants market. The market is well-established in North America, with the US dominating the market in this region. The large share of North America is mainly attributed to the established healthcare infrastructure, higher adoption of sophisticated healthcare technologies, higher budget among end users of ophthalmic devices, and a large number of manufacturers for corneal implants in the region.
• By Company: Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
• By Designation: C-level Executives: 25%, Directors: 55%, and Others: 20%
• By Region: North America: 40%, Europe: 25%, APAC: 20%, LATAM: 10% and MEA: 5%

Some of the key players in the artificial cornea and corneal implant market are AJL Ophthalmic (Spain), CorneaGen Inc. (US), Addition Technology, Inc. (US), LinkoCare Life Sciences AB (Sweden), Presbia plc (Ireland), Mediphacos (Brazil), Aurolab (India), Cornea Biosciences (US), DIOPTEX GmbH (Austria), EyeYon Medical (Israel), Massachusetts Eye and Ear (US), Florida Lions Eye Bank (US), SightLife (US), Advancing Sight Network (US), San Diego Eye Bank (US), L V Prasad Eye Institute (LVPEI, India), New Mexico Lions Eye Bank (NMLEB, US), San Antonio Eye Bank (US), Kansas Eye Bank & Cornea Research Center (US), Rocky Mountain Lions Eye Bank (US), Netherlands Institute for Innovative Ocular Surgery (NIIOS, Netherlands), CTS Eye Bank (UK), The East Anglian Eye Bank (UK), Kensington Health (Canada), and Beijing Tongren Eye Bank (China). The study includes an in-depth competitive analysis of these key players in the artificial cornea and corneal implant market, along with their company profiles, recent developments, and key market strategies.
Research Coverage:
The market study covers the artificial cornea and corneal implant market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, transplant type, disease indication, end users and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the artificial cornea and corneal implant market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide information on key market drivers, restraints, opportunities and challenges.

1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS & EXCLUSIONS 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 YEARS CONSIDERED FOR THE STUDY 24
1.4 CURRENCY 25
1.5 LIMITATIONS 25
1.6 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH DATA 26
FIGURE 1 RESEARCH DESIGN 26
2.1.1 SECONDARY DATA 27
2.1.1.1 Key data from secondary sources 27
2.1.2 PRIMARY DATA 28
FIGURE 2 PRIMARY SOURCES 28
2.1.2.1 Key data from primary sources 29
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 29
2.2 MARKET SIZE ESTIMATION 30
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2020) 31
FIGURE 5 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2021–2026) 32
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 33
FIGURE 6 DATA TRIANGULATION METHODOLOGY 33
2.4 ASSUMPTIONS FOR THE STUDY 34
3 EXECUTIVE SUMMARY 35
FIGURE 7 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 35
FIGURE 8 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2021 VS. 2026 (USD MILLION) 36
FIGURE 9 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2021 VS. 2026 (USD MILLION) 36
FIGURE 10 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 37
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET 38
4 PREMIUM INSIGHTS 39
4.1 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET OVERVIEW 39
FIGURE 12 RISING PREFERENCE OF EYE DISEASES TO DRIVE MARKET GROWTH 39
4.2 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TYPE AND END USER (2020) 40
FIGURE 13 HUMAN CORNEA SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF
THE APAC MARKET IN 2020 40
4.3 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION, 2021−2026 40
FIGURE 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET IN THE FORECAST PERIOD 40
4.4 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET:
DEVELOPING VS. DEVELOPED MARKETS 41
FIGURE 15 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING
THE FORECAST PERIOD 41
4.5 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 42
FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
TABLE 1 MARKET DYNAMICS: IMPACT ANALYSIS 43
5.2.1 MARKET DRIVERS 43
5.2.1.1 Rapid growth in the geriatric population 43
FIGURE 17 GERIATRIC POPULATION AS A PERCENTAGE OF THE TOTAL POPULATION,
BY REGION, 2017 VS. 2050 44
5.2.1.2 Rising prevalence of eye diseases 44
5.2.1.2.1 Corneal blindness 45
5.2.1.2.2 Cataracts 45
TABLE 2 TOTAL NUMBER OF CATARACT SURGICAL PROCEDURES PERFORMED,
BY COUNTRY, 2017 VS. 2018 45
5.2.1.2.3 Glaucoma 46
TABLE 3 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE,
2013 VS. 2020 VS. 2040 (MILLION) 46
5.2.1.2.4 Obesity and diabetes 46
TABLE 4 NUMBER OF PEOPLE WITH DIABETES, BY REGION,
2019 VS. 2030 VS. 2045 (MILLION) 47
5.2.1.3 Increasing government initiatives to control visual impairment 47
5.2.2 RESTRAINTS 48
5.2.2.1 High cost of ophthalmology devices and surgical procedures 48
5.2.3 OPPORTUNITIES 48
5.2.3.1 Shortage of corneal donors 48
5.2.3.2 Untapped potential of emerging markets 48

5.2.4 CHALLENGES 49
5.2.4.1 Lack of awareness and low access to eye care in low-income economies 49
5.2.4.2 Shortage of ophthalmologists 50
6 INDUSTRY INSIGHTS 51
6.1 INTRODUCTION 51
6.2 INDUSTRY TRENDS 51
6.2.1 3D-PRINTED HUMAN CORNEAS 51
6.2.2 OCT ANGIOGRAPHY DEVICES 51
6.2.3 ADVANCES IN REFRACTIVE SURGERY 52
6.3 IMPACT OF COVID-19 ON THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET 52
6.4 VALUE CHAIN ANALYSIS 53
FIGURE 18 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: VALUE CHAIN ANALYSIS 53
6.5 ECOSYSTEM 54
FIGURE 19 ECOSYSTEM: ARTIFICIAL CORNEAL IMPLANTS MARKET (2019) 54
6.6 REGULATORY ANALYSIS 54
TABLE 5 STRINGENCY OF REGULATIONS FOR OPHTHALMIC EQUIPMENT, BY REGION 54
6.6.1 NORTH AMERICA 55
6.6.1.1 US 55
TABLE 6 US: CLASSIFICATION OF OPHTHALMIC EQUIPMENT 55
TABLE 7 US: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 55
6.6.1.2 Canada 56
TABLE 8 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF
THE REGISTRATION PROCESS 56
6.6.2 EUROPE 56
TABLE 9 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF
THE REGISTRATION PROCESS 57
TABLE 10 EUROPE: CLASSIFICATION OF ARTIFICIAL CORNEAL IMPLANTS ALONG WITH OTHER OPHTHALMIC EQUIPMENT 57
6.6.3 ASIA PACIFIC 58
6.6.3.1 Japan 58
TABLE 11 JAPAN: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 58
6.6.3.2 China 59
TABLE 12 CHINA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 59
7 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE 60
7.1 INTRODUCTION 61
TABLE 13 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 61
7.2 HUMAN CORNEA 61
7.2.1 INCREASING PREVALENCE OF CORNEAL BLINDNESS TO DRIVE MARKET GROWTH 61
TABLE 14 US: TOTAL DONATIONS AND DISTRIBUTION OF TISSUE, 2019 62
FIGURE 20 US: CORNEAL TRANSPLANT SUPPLIED BY EYE BANKS, 2010−2019 62
TABLE 15 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR HUMAN CORNEA, BY COUNTRY, 2019–2026 (USD MILLION) 63
7.3 ARTIFICIAL CORNEA 63
7.3.1 SCARCITY OF HUMAN EYE DONORS HAS PROPELLED MARKET GROWTH 63
TABLE 16 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR ARTIFICIAL CORNEA, BY COUNTRY, 2019–2026 (USD MILLION) 64
8 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE 65
8.1 INTRODUCTION 66
TABLE 17 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 66
FIGURE 21 US: SURGERY TRENDS, 2010−2019 66
8.2 PENETRATING KERATOPLASTY 67
8.2.1 PK ENABLES THE ABILITY TO TREAT KERATITIS AND INJURY OF THE EYEBALL 67
TABLE 18 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR PENETRATING KERATOPLASTY, BY COUNTRY, 2019–2026 (USD MILLION) 67
8.3 ENDOTHELIAL KERATOPLASTY 68
8.3.1 ADVANTAGES SUCH AS FASTER VISUAL RECOVERY AND LESS PRONE TO INJURY ARE SUPPORTING THE GROWTH OF THIS SEGMENT 68
TABLE 19 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR ENDOTHELIAL KERATOPLASTY, BY COUNTRY, 2019–2026 (USD MILLION) 68
8.4 OTHER TRANSPLANTS 69
TABLE 20 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR OTHER TRANSPLANTS, BY COUNTRY, 2019–2026 (USD MILLION) 69
9 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION 70
9.1 INTRODUCTION 71
TABLE 21 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 71
9.2 FUCHS’ DYSTROPHY 71
9.2.1 RISING PREVALENCE OF FUCHS’ DYSTROPHY IS THE KEY FACTOR DRIVING MARKET GROWTH 71
TABLE 22 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR FUCHS’ DYSTROPHY, BY COUNTRY, 2019–2026 (USD MILLION) 72
9.3 FUNGAL KERATITIS 72
9.3.1 LARGE PATIENT POPULATION SUFFERING FROM FUNGUS KERATITIS TO DRIVE MARKET GROWTH 72
TABLE 23 ESTIMATED ANNUAL INCIDENCE OF FUNGAL KERATITIS, BY REGION (2019) 73
TABLE 24 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR FUNGAL KERATITIS, BY COUNTRY, 2019–2026 (USD MILLION) 73

9.4 KERATOCONUS 74
9.4.1 INCREASING RESEARCH ON KERATOCONUS TREATMENT TO SUPPORT MARKET GROWTH 74
TABLE 25 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR KERATOCONUS, BY COUNTRY, 2019–2026 (USD MILLION) 74
9.5 OTHER DISEASES 75
TABLE 26 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 75
10 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER 76
10.1 INTRODUCTION 77
TABLE 27 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION) 77
10.2 IMPACT OF COVID-19 ON THE END-USER MARKET 77
10.3 HOSPITALS 77
10.3.1 LARGE PATIENT POOL AND HIGH PURCHASING POWER OF HOSPITALS ARE THE KEY FACTORS DRIVING MARKET GROWTH 77
TABLE 28 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR HOSPITALS,
BY COUNTRY, 2019–2026 (USD MILLION) 78
10.4 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS 78
10.4.1 COST-EFFECTIVENESS OF AMBULATORY CARE HAS RESULTED IN GROWING END-USER INTEREST TOWARDS ASCS 78
TABLE 29 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS, BY COUNTRY,
2019–2026 (USD MILLION) 79
11 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION 80
11.1 INTRODUCTION 81
TABLE 30 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION,
2019–2026 (USD MILLION) 81
TABLE 31 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 82
11.2 NORTH AMERICA 82
TABLE 32 EYE BANKING STATISTICS IN NORTH AMERICA REPORTED BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019) 83
FIGURE 22 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET SNAPSHOT 84
TABLE 33 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 85
TABLE 34 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 85
TABLE 35 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 85
TABLE 36 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 86
TABLE 37 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 86

11.2.1 US 86
11.2.1.1 The US dominates the artificial cornea and corneal implants market 86
FIGURE 23 EYE BANKING STATISTICS IN THE US: AVERAGE CORNEAS RECOVERED FOR TRANSPLANT (2011-2019) 87
TABLE 38 US: KEY MACROINDICATORS 87
TABLE 39 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 87
TABLE 40 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 88
TABLE 41 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 88
TABLE 42 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION) 88
11.2.2 CANADA 89
11.2.2.1 Growing number of cataract and diabetic retinopathy cases to propel market growth 89
TABLE 43 CANADA: KEY MACROINDICATORS 89
TABLE 44 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 89
TABLE 45 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 90
TABLE 46 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 90
TABLE 47 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 90
11.3 EUROPE 91
TABLE 48 EYE BANKING STATISTICS IN EUROPE REPORTED BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019) 91
TABLE 49 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 92
TABLE 50 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 92
TABLE 51 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 92
TABLE 52 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 93
TABLE 53 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 93
11.3.1 GERMANY 93
11.3.1.1 Established healthcare infrastructure and higher healthcare spending to drive the market growth 93
TABLE 54 GERMANY: KEY MACROINDICATORS 94
TABLE 55 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 94
TABLE 56 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 94
TABLE 57 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 95
TABLE 58 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 95
11.3.2 UK 95
11.3.2.1 Rising prevalence of diabetes and related eye diseases to support market growth 95
FIGURE 24 UK: NUMBER OF CORNEAS RETRIEVED TO NHSBT EYE BANKS AND CORNEAS GRAFTED 96
FIGURE 25 UK: NUMBER OF CORNEAL TRANSPLANTS, BY INDICATION, 2010−2020 96
TABLE 59 UK: KEY MACROINDICATORS 97
TABLE 60 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 97
TABLE 61 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 97
TABLE 62 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 98
TABLE 63 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION) 98
11.3.3 FRANCE 98
11.3.3.1 Growing awareness of eye health to drive the market growth in France 98
TABLE 64 FRANCE: KEY MACROINDICATORS 99
TABLE 65 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 99
TABLE 66 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 99
TABLE 67 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 100
TABLE 68 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 100
11.3.4 REST OF EUROPE 100
FIGURE 26 ITALY: NUMBER OF CORNEA DONATIONS, 2014-2019 101
TABLE 69 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 101
TABLE 70 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 101
TABLE 71 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 102
TABLE 72 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION) 102
11.4 ASIA PACIFIC 102
TABLE 73 EYE BANKING STATISTICS IN THE ASIA PACIFIC REPORTED
BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019) 103
FIGURE 27 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET SNAPSHOT 104
TABLE 74 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 75 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 105
TABLE 76 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 105
TABLE 77 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 106
TABLE 78 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 106
11.4.1 CHINA 106
11.4.1.1 China to register the highest growth rate in the artificial cornea and corneal implants market 106
TABLE 79 CHINA: KEY MACROINDICATORS 107
TABLE 80 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 107
TABLE 81 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 108
TABLE 82 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 108
TABLE 83 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 108
11.4.2 JAPAN 109
11.4.2.1 Large geriatric population in the country to support market growth 109
TABLE 84 JAPAN: KEY MACROINDICATORS 109
TABLE 85 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 86 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 110
TABLE 87 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 110
TABLE 88 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 110
11.4.3 REST OF ASIA PACIFIC 111
TABLE 89 INDIA: NUMBER OF DONATED EYES FOR CORNEAL TRANSPLANTATION 112
TABLE 90 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 112
TABLE 91 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 112
TABLE 92 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 113
TABLE 93 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 113
11.5 LATIN AMERICA 113
11.5.1 GOVERNMENT INITIATIVES TO INCREASE AWARENESS ABOUT VISION CARE TO SUPPORT MARKET GROWTH 113
TABLE 94 ESTIMATED ANNUAL INCIDENCE OF FUNGAL KERATITIS IN LATIN AMERICA 114
FIGURE 28 NUMBER OF CORNEA TRANSPLANTS PERFORMED IN BRAZIL AND MEXICO FROM 2010 TO 2019 (THOUSAND) 114
TABLE 95 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 114
TABLE 96 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 115
TABLE 97 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY DISEASE INDICATION, 2019–2026 (USD MILLION) 115
TABLE 98 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 115
11.6 MIDDLE EAST & AFRICA 116
11.6.1 RISING MEDICAL TOURISM IS THE KEY GROWTH DRIVER FOR THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET IN THE MEA 116
TABLE 99 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 116
TABLE 100 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION) 117
TABLE 101 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION) 117
TABLE 102 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION) 117
12 COMPETITIVE LANDSCAPE 118
12.1 OVERVIEW 118
FIGURE 29 KEY DEVELOPMENTS IN THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FROM JANUARY 2018 TO DECEMBER 2020 118
FIGURE 30 MARKET EVALUATION FRAMEWORK: OTHER DEVELOPMENTS WAS THE MOST WIDELY ADOPTED STRATEGY BETWEEN 2018 & 2020 119
12.2 ARTIFICIAL CORNEA MARKET RANKING 119
12.3 HUMAN CORNEA MARKET RANKING 120
12.4 PRODUCT BENCHMARKING 120
FIGURE 31 PRODUCT PORTFOLIO ANALYSIS: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2020) 121
12.5 COMPETITIVE SITUATIONS & TRENDS 121
12.5.1 PRODUCT LAUNCHES & APPROVALS 121
12.5.2 ACQUISITIONS 121
12.5.3 EXPANSIONS 122
12.5.4 OTHER DEVELOPMENTS 122
13 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY AND COMPANY PROFILES 123
13.1 COMPETITIVE LEADERSHIP MAPPING 123
13.1.1 STARS 123
13.1.2 EMERGING LEADERS 123
13.1.3 PERVASIVE COMPANIES 124
13.1.4 EMERGING COMPANIES 124
FIGURE 32 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 124

13.2 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS 125
13.2.1 PROGRESSIVE COMPANIES 125
13.2.2 DYNAMIC COMPANIES 125
13.2.3 STARTING BLOCKS 125
13.2.4 RESPONSIVE COMPANIES 125
FIGURE 33 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: STARTUP COMPANY EVALUATION MATRIX (2020) 126
13.3 COMPANY PROFILES 127
(Business overview, Products offered, Recent developments)*
13.3.1 AJL OPHTHALMIC S.A. 127
13.3.2 CORNEAGEN, INC. 128
13.3.3 ADDITION TECHNOLOGY, INC. 129
13.3.4 LINKOCARE LIFE SCIENCES AB 130
13.3.5 PRESBIA PLC 131
FIGURE 34 PRESBIA PLC: COMPANY SNAPSHOT (2018) 131
13.3.6 MEDIPHACOS 132
13.3.7 AUROLAB 133
13.3.8 CORNEA BIOSCIENCES, INC. 134
13.3.9 DIOPTEX MEDIZINPRODUKTE FORSCHUNGS-, ENTWICKLUNGS- UND VERTRIEBS GMBH (DIOPTEX GMBH) 135
13.3.10 EYEYON MEDICAL 136
13.3.11 MASSACHUSETTS EYE AND EAR 137
FIGURE 35 MASSACHUSETTS EYE AND EAR: COMPANY SNAPSHOT (2020) 137
13.3.12 FLORIDA LIONS EYE BANK 138
FIGURE 36 FLORIDA LIONS EYE BANK: COMPANY SNAPSHOT (2019) 138
13.3.13 SIGHTLIFE 139
FIGURE 37 SIGHTLIFE: COMPANY SNAPSHOT (2019) 139
13.3.14 ADVANCING SIGHT NETWORK 140
13.3.15 SAN DIEGO EYE BANK 141
13.3.16 L V PRASAD EYE INSTITUTE 142
13.3.17 NEW MEXICO LIONS EYE BANK 143
13.3.18 SAN ANTONIO EYE BANK 144
13.3.19 KANSAS EYE BANK & CORNEA RESEARCH CENTER 145
13.3.20 ROCKY MOUNTAIN LIONS EYE BANK 146
13.3.21 CORNEAT VISION 147
13.3.22 KERAMED, INC. 148
*Business overview, Products offered, Recent developments might not be captured in case of unlisted companies.

14 APPENDIX 149
14.1 INSIGHTS OF INDUSTRY EXPERTS 149
14.2 DISCUSSION GUIDE 150
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 153
14.4 AVAILABLE CUSTOMIZATIONS 155
14.5 AUTHOR DETAILS 156

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+